Emcure Pharmaceuticals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EMCURE.BO | TAK | TEVA | LUPIN.NS | NOVARTIND.BO | AUROPHARMA.BO | |
|---|---|---|---|---|---|---|
| Market cap | 342.64B | 62.95B | 48.27B | 886.78B | 47.48B | 957.75B |
| P/E (TTM) | 33.9 | — | 69.0 | 16.1 | 48.5 | 28.0 |
| Forward P/E | 23.2 | 37.2 | 13.4 | 19.1 | — | 22.0 |
| Price/book | 6.9 | 1.3 | 6.2 | 3.9 | 5.8 | 2.7 |
| Dividend yield | 0.20% | 3.13% | — | 0.92% | — | 0.33% |
| 1-year change | +32.44% | +39.70% | +113.70% | +0.92% | +120.48% | +1.70% |
| Today | −0.93% | +0.18% | −0.26% | −1.14% | +1.17% | −0.81% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All EMCURE.BO news ›Emcure Pharmaceuticals Merges Two Wholly-Owned Subsidiaries
Rediff MoneyWiz Key PointsEmcure Pharmaceuticals approved the merger of its wholly-owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals.The merger aims to achieve entity rationalization and operational efficiency within…
Emcure Pharmaceuticals board approves draft merger scheme with Zuventus Healthcare and Emcutix Biopharmaceuticals
The scheme was approved at a board meeting held on October 12, 2026. Under the proposed arrangement, both subsidiaries will be merged with Emcure Pharmaceuticals, subject to the necessary statutory and regulatory approvals. The proposed…
Gilead Sciences, Inc. Expands Royalty-Free Voluntary Licensing Agreements For Lenacapavir With Dr. Reddy?s Laboratories Limited, Emcure Pharmaceuticals Limited, Eva Pharma For Pharmaceutical Industries S.A.E., Ferozsons Laboratories Limited, Hetero And Mylan Laboratories Limited
Gilead Sciences, Inc. announced that it has expanded the scope of its six royalty-free voluntary licensing agreements for lenacapavir to include investigational once-yearly lenacapavir for HIV... announced that it has expanded the scope of…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
businessupturn.com2
-
kalkine.co.in1
-
marketscreener.com1
-
money.rediff.com1
-
news18.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.